130 related articles for article (PubMed ID: 29708091)
1. Impact of 2018 Changes in National Healthcare Safety Network Surveillance for Clostridium difficile Laboratory-Identified Event Reporting.
Marra AR; Edmond MB; Ford BA; Herwaldt LA; Algwizani AR; Diekema DJ
Infect Control Hosp Epidemiol; 2018 Jul; 39(7):886-888. PubMed ID: 29708091
[No Abstract] [Full Text] [Related]
2. Evaluating the Use of the Case Mix Index for Risk Adjustment of Healthcare-Associated Infection Data: An Illustration using Clostridium difficile Infection Data from the National Healthcare Safety Network.
Thompson ND; Edwards JR; Dudeck MA; Fridkin SK; Magill SS
Infect Control Hosp Epidemiol; 2016 Jan; 37(1):19-25. PubMed ID: 26486597
[TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile-the next step in mandatory reporting.
Barrett S
J Hosp Infect; 2004 Feb; 56(2):83-4. PubMed ID: 15019217
[No Abstract] [Full Text] [Related]
4. A Successful Strategy to Decrease Hospital-Onset Clostridium difficile.
Bruno-Murtha LA; Osgood RA; Alexandre CE
Infect Control Hosp Epidemiol; 2018 Feb; 39(2):234-236. PubMed ID: 29301591
[No Abstract] [Full Text] [Related]
5. How to: Surveillance of Clostridium difficile infections.
Krutova M; Kinross P; Barbut F; Hajdu A; Wilcox MH; Kuijper EJ;
Clin Microbiol Infect; 2018 May; 24(5):469-475. PubMed ID: 29274463
[TBL] [Abstract][Full Text] [Related]
6. Impact of mandatory Clostridium difficile surveillance on diagnostic services.
Berrington A
J Hosp Infect; 2004 Nov; 58(3):241-2. PubMed ID: 15501344
[No Abstract] [Full Text] [Related]
7. Viral gastroenteritis increases the reports of Clostridium difficile infection.
Wilcox M; Fawley W
J Hosp Infect; 2007 Aug; 66(4):395-6. PubMed ID: 17662506
[No Abstract] [Full Text] [Related]
8. Immediate impact of healthcare-facility-onset Clostridium difficile laboratory-identified events reporting methodology change on standardized infection ratios.
Figueroa Castro CE; Palen L; Johnson C; Graham MB; Letzer D; Ledeboer N; Buchan B; Block T; Seliger H; Singh S; Behrens E; Huerta S; Munoz-Price LS
Infect Control Hosp Epidemiol; 2018 Dec; 39(12):1484-1486. PubMed ID: 30348236
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile infection: a comprehensive review.
Kachrimanidou M; Malisiovas N
Crit Rev Microbiol; 2011 Aug; 37(3):178-87. PubMed ID: 21609252
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile surveillance: a multicenter comparison of LabID events and use of standard definitions.
Baier R; Morphis B; Marsella M; Mermel LA
Infect Control Hosp Epidemiol; 2013 Jun; 34(6):653-5. PubMed ID: 23651906
[No Abstract] [Full Text] [Related]
11. Increased detection of Clostridium difficile during a norovirus outbreak.
Barrett SP; Holmes AH; Newsholme WA; Richards M
J Hosp Infect; 2007 Aug; 66(4):394-5. PubMed ID: 17669553
[No Abstract] [Full Text] [Related]
12. National variability in surveillance, testing, and infection prevention for Clostridium difficile infection in pediatric populations.
Kociolek LK; Sandora TJ
Am J Infect Control; 2013 Oct; 41(10):933-5. PubMed ID: 23790613
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 2 Clostridium difficile surveillance methods: National Healthcare Safety Network's laboratory-identified event reporting module versus clinical infection surveillance.
Gase KA; Haley VB; Xiong K; Van Antwerpen C; Stricof RL
Infect Control Hosp Epidemiol; 2013 Mar; 34(3):284-90. PubMed ID: 23388363
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile infection targets.
Hill SF
J Hosp Infect; 2015 Feb; 89(2):136-7. PubMed ID: 25575770
[No Abstract] [Full Text] [Related]
15. Potential for the current National Healthcare Safety Network (NHSN) >3 days after admission definition of laboratory-identified, healthcare-facility-onset,
Puri S; Hughes HY; McCrackin MD; Williford R; Gebregziabher M; Salgado CD; Curry SR
Infect Control Hosp Epidemiol; 2020 Apr; 41(4):467-468. PubMed ID: 31973777
[TBL] [Abstract][Full Text] [Related]
16. What's lurking under the bed? Persistence and predominance of particular Clostridium difficile strains in a hospital and the potential role of environmental contamination.
McFarland LV
Infect Control Hosp Epidemiol; 2002 Nov; 23(11):639-40. PubMed ID: 12452289
[No Abstract] [Full Text] [Related]
17. Failure of Risk-Adjustment by Test Method for C. difficile Laboratory-Identified Event Reporting.
Marra AR; Edmond MB; Ford BA; Herwaldt LA; Algwizani AR; Diekema DJ
Infect Control Hosp Epidemiol; 2017 Jan; 38(1):109-111. PubMed ID: 27745553
[TBL] [Abstract][Full Text] [Related]
18. Ribotyping in the detection of Clostridium difficile outbreaks in a single university hospital.
Patel TA; Smith R; Hopkins S
J Hosp Infect; 2013 Jan; 83(1):77-9. PubMed ID: 23158685
[TBL] [Abstract][Full Text] [Related]
19. Rate of Clostridioides difficile Culture Positivity Among Hospitalized Patients.
Lonks JR; Nolette E; Cadnum JL; Donskey CJ
R I Med J (2013); 2020 Mar; 103(2):28-30. PubMed ID: 32122097
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive surveillance, control and management programme for Clostridium difficile infection.
Guzmán A; Del Mar Portillo M; López-Cerero L; García-Ortega L; Lupión C; González C; Gálvez J; Muniain MA; Dolores Del Toro M; Domínguez A; Pascual A; Rodríguez-Baño J
J Hosp Infect; 2010 Jan; 74(1):91-3. PubMed ID: 19765860
[No Abstract] [Full Text] [Related]
[Next] [New Search]
